190,213 GLP-1 receptor agonists act by binding to and amplifying activation of the GLP-1 receptor, resulting in enhanced post-prandial insulin secretion, glucagon release inhibition, delayed gastric emptying and appetite suppression
The interplay between obesity, weight loss, anti-obesity medication, and suicidal ideation is complex
Bei bermssigem Gewichtsverlust und erhhtem Sarkopenierisiko sind Anpassungen der Therapie erforderlich, insbesondere hinsichtlich der Dosierung des GLP-1-RA, der Mahlzeitenzusammensetzung, der Portionsgrssen, des Mahlzeitenrhythmus sowie der krperlichen Aktivitt
Therefore, we conducted a systematic review to examine whether OA progression in patients with type 2 diabetes was affected by metformin treatment The systematic review revealed that type 2 diabetes patients treated with metformin showed a lower incidence of knee arthroplasty (Fig
Cultures were pulse-labeled with 10 M BrdU (a nucleoside analog that competes with thymidine for incorporation into DNA) in DMEM-10% HS for the final 2-h period of 48-h in culture, followed by immunocytochemistry for detection of BrdU using G3G4 anti-BrdU mAb (1:100 dilution) and HRP-conjugated anti-mouse IgG Ab (1:500 dilution)